tiprankstipranks
MariMed Inc (TSE:MRMD)
CNQX:MRMD
Holding TSE:MRMD?
Track your performance easily

MariMed (MRMD) Income Statement

3 Followers

MariMed Income Statement

Last quarter (Q3 2024), MariMed's total revenue was $40.59M, an increase of 11.15% from the same quarter last year. In Q3, MariMed's net income was $-1.01M. See MariMed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 157.76M$ 148.60M$ 134.01M$ 121.46M$ 50.90M$ 45.60M
Cost of Revenue
$ 90.77M$ 82.68M$ 70.05M$ 55.20M$ 19.57M$ 26.90M
Gross Profit
$ 67.00M$ 65.92M$ 63.96M$ 66.26M$ 31.32M$ 18.70M
Operating Expense
$ 59.39M$ 51.53M$ 43.59M$ 39.40M$ 16.79M$ 57.53M
Operating Income
$ 7.61M$ 14.38M$ 20.37M$ 26.86M$ 14.53M$ -38.83M
Net Non Operating Interest Income Expense
$ -4.01M$ -8.91M$ -734.00K$ -2.25M$ -9.65M$ -12.89M
Other Income Expense
$ 696.00K$ -12.88M$ -4.84M$ 800.00K$ 380.21K$ 27.39M
Pretax Income
$ -522.00K$ -6.60M$ 19.51M$ 23.82M$ 4.50M$ -76.45M
Tax Provision
$ 7.67M$ 9.41M$ 5.89M$ 16.19M$ 2.07M$ 67.16K
Earnings From Equity Interest Net Of Tax
----$ 98.81K$ -30.33M
Net Income Common Stockholders
$ -6.50M$ -16.03M$ 13.47M$ 7.22M$ 2.14M$ -75.82M
Basic EPS
$ -0.01$ -0.04$ 0.04$ 0.02$ 0.01$ -0.39
Diluted EPS
$ -0.01$ -0.04$ 0.04$ 0.02$ 0.01$ -0.39
Basic Average Shares
$ 1.51B$ 363.40M$ 337.70M$ 326.47M$ 266.98M$ 208.72M
Diluted Average Shares
$ 1.51B$ 363.40M$ 380.29M$ 372.40M$ 324.16M$ 208.72M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 150.15M$ 134.21M$ 108.93M$ 94.60M$ 36.36M$ 84.43M
Net Income From Continuing And Discontinued Operation
$ -8.22M$ -16.03M$ 13.47M$ 7.22M$ 2.14M$ -75.82M
Normalized Income
$ 97.15K-----
Interest Expense
------
EBIT
$ 5.46M$ 2.59M$ 21.20M$ 26.17M$ 14.31M$ -63.73M
EBITDA
$ 16.25M$ 14.25M$ 25.91M$ 28.96M$ 16.49M$ -52.58M
Currency in USD

MariMed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis